Today’s breast cancer trials aren’t just testing small improvements. Many are exploring entirely new ways to treat cancer, reduce side effects, and personalize care. Understanding what is being studied right now can help you have more informed conversations with your care team and feel more confident about what may be available to you. Clinical trials […]

Key CDK 4/6 clinical trial results with Dr. Steven Isakoff and Dr. Hope Rugo New data and research is constantly emerging in breast cancer care. Following this past year’s major scientific conferences in breast cancer, we spoke with breast oncologist Dr. Hope Rugo and medical oncologist Dr. Steven Isakoff about the latest treatment options for […]

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy. Watch an exclusive “Ask the Expert” webinar: “Advancing Breast Cancer Treatment From Trials to Clinical Practice.” Featuring renowned breast oncologist Dr. Eleonora Teplinsky, Head, Breast and […]

Recently, the Outcomes4Me team had an incredible opportunity to attend the Ellie Fund and Boston Breast Cancer Equity Coalition’s symposium: “Clinical Trials: A Real Treatment Option for Breast Cancer Patients” where we participated in an important conversation about how patient-centricity, diversity, trust-building, and collaboration play essential roles in improving clinical trial inclusivity and, ultimately, health […]

There are a lot of misconceptions about clinical trials but the reality is that these studies are safe to partake in and they exist for all stages of breast cancer. That’s why we’re sharing this clinical trial patient story from our Director of Marketing & Community, Suzanne Garner. She shares her experience finding a trial […]

Today, Novartis announced the first results of a Phase III trial for a CDK4/6 inhibitor for early breast cancer. The NATALEE trial showed Kisqali® plus endocrine therapy significantly reduced the risk of disease recurrence for patients with HR+/HER2- early breast cancer compared to endocrine therapy alone. What is a CDK4/6 inhibitor?CDK4/6 inhibitors are the clinical […]

Recently, Outcomes4Me Founder and CEO Dr. Maya R. Said sat down with Dr. Sonya Reid, a breast oncologist from Vanderbilt-Ingram Cancer Center, for an “Ask the Expert” Q&A on breast cancer clinical trials. Tune in to this webinar recording to find out if clinical trials are right for you. Hear Dr. Reid’s answers to the […]

Clinical trials are research studies involving people aimed at evaluating a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment, like a new drug or diet, or medical device is safe and effective in people. Often, a clinical trial (under careful supervision) is used to learn […]

We have included the entire video above for anyone who missed it and wants to watch it in full.  Here is a recap of the key takeaways from the discussion with Dr. Tolaney: >> Let’s start off with clinical trials. What are the basics of clinical trials that patients need to know? There are different […]